TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Palette Life Sciences AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
5,503
|
32,202
|
18,556 |
| Financial expenses |
3,565
|
3,630
|
1,346 |
| Earnings before taxes |
-30,769
|
-29,244
|
-22,063 |
| EBITDA |
-30,251
|
-25,442
|
-20,546 |
| Total assets |
79,341
|
33,627
|
18,910 |
| Current assets |
7,008
|
23,139
|
18,034 |
| Current liabilities |
40,845
|
21,513
|
4,382 |
| Equity capital |
38,496
|
-12,751
|
5,430 |
| - share capital |
278
|
277
|
263 |
| Employees (average) |
2
|
84
|
49 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
48.5%
|
-37.9%
|
28.7% |
| Turnover per employee |
2,752
|
383
|
379 |
| Profit as a percentage of turnover |
-559.1%
|
-90.8%
|
-118.9% |
| Return on assets (ROA) |
-34.3%
|
-76.2%
|
-109.6% |
| Current ratio |
17.2%
|
107.6%
|
411.5% |
| Return on equity (ROE) |
-79.9%
|
229.3%
|
-406.3% |
| Change turnover | |||
| Change turnover % | 89% | ||
| Chg. No. of employees | |||
| Chg. No. of employees % | 71% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.